Treating Pediatric and Adolescent Influenza

0.75 CME
0.75 CNE
45 MINS
$0 FEE
SAVE
Treating Pediatric Influenza in 2020

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from Genentech, Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Activity Description

Although the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation of the impact associated with a pandemic. Antiviral agents with different targets and mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this educational activity, expert clinicians will discuss the latest evidence on diagnosing and treating influenza.


Target Audience

The intended audience for this activity is pediatricians, primary care physicians, nurses, nurse practitioners, and other health care professionals involved in the management of patients with influenza.


Learning Objective(s)

Upon successful completion of this activity, participants should be better able to:

Physician

  • Utilize diagnostic assays that aid in the early detection of influenza in the pediatric population.
  • Apply new evidence to practice regarding the use of antivirals in pediatric and adolescent patients with influenza who are at normal or high risk for complications.

Nurse

  • Utilize diagnostic assays that aid in the early detection of influenza in the pediatric population.
  • Summarize new evidence about the efficacy of antivirals in pediatric and adolescent patients with influenza who are at normal or high risk for complications.

Activity Chair

John J. Russell, MD, FAAFP
Clinical Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency
Abington – Jefferson Health
Abington, PA


Faculty

Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP
Professor
University of Louisville School of Medicine
Division of Infectious Diseases
Louisville, KY


Nurse Planners

Barbara A. Niedz, PhD, RN, CPHQ
Patricia A. Stinchfield, MS, CPNP, CIC


Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Ronald A. Codario, Jr., MD


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education, LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education will provide a maximum of 0.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to: 

0.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and 
abp moc 0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. 
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

This enduring material is approved for 1 year from the date of original release, January 15, 2021, through January 14, 2022.


How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or Contact Hours Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control.

Activity Chair and Faculty report the following relationship(s)

Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP
Speakers Bureau: Pfizer, Sanofi Pasteur
Contracted Research: Pfizer

John J. Russell, MD, FAAFP
Consulting Fee: Bayer, GlaxoSmithKline, Sanofi Pasteur
Speakers Bureau: Sanofi Pasteur

Nurse Planners report the following relationship(s)

Barbara A. Niedz, PhD, RN, CPHQ
Consulting Fee: Beckton Dickinson
Contracted Research: Beckton Dickinson

Patricia A. Stinchfield, MS, CPNP, CIC
No relevant financial relationships to disclose.

Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Ronald A. Codario, Jr., MD
Disclosures: No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com